The European Council, the European Parliament, and the outgoing European Commission have agreed upon the priorities and structure of Horizon Europe (2021 to 2027), the next seven-year research and innovation programme of the European Union. This autumn, they will decide on the Parliament’s proposal to increase its budget from €100bn to €120bn.
Jens-Peter Marschner joins Zelluna
AppointmentsZelluna Immunotherapy, a biotechnology company specializing in T-cell receptor (TCR) immunotherapies, announced the appointment of Jens-Peter Marschner as chief medical officer (CMO) at the end of June.
Bioeconomy: just a way to set up a smarter agriculture?
BackgroundOutgoing EU Commissioner for Agriculture Paul Hogan said in April, that the European Commission will exclude member states from the future Common Agricultural Policy (CAP) that do not include the promotion of the bioeconomy in agriculture.
Drug puts CAR T activity on hold
Latest NewsGerman researchers have found a way to curb the activity of CAR T cells, even while keeping their cancer-fighting properties intact.
Biotech company Galapagos improves high-content screening (HCS) in scleroderma with IN Carta Phenoglyphs image analysis
Sponsored PublicationsGalapagos’s mission is to develop first-in-class medicines based on the discovery of novel targets. Using human primary healthy andpatient cells, the company discovers which proteins play a key role in diseases such as rheumatoid arthritis, inflammatory bowel disease, and fibrosis.
License deal in oncolytic virotherapies
Latest NewsOncovita has been granted the exclusive license to an immuno-oncolytic measles virus platform developed by the Institut Pasteur. Based on the technology, the Paris-based biotech plans to develop cancer therapies.
Helena Strigård becomes CEO of Swedenbio
AppointmentsSwedenbio’s Board has appointed Helena Strigård as the new CEO. Strigård will take up the position on September 1 and replace Jonas Ekstrand,
Teckro Expands Leadership Team
AppointmentsTeckro today announced five significant appointments to its leadership team. The hires follow Teckro’s Series C funding announcement in February, featuring investment from major US venture capital firms. To date, Teckro has raised $43 million.
Boehringer Ingelheim and Yuhan Corp. in US$870m NASH deal
Latest NewsSmart bra set to detect breast cancer
Latest NewsA French-Swiss research team is developing a smart bra for detecting breast cancer more accessible than through mammography.
Trilogue put lights on green for Horizon Europe
BackgroundThe European Council, the European Parliament, and the outgoing European Commission have agreed upon the priorities and structure of Horizon Europe (2021 to 2027), the next seven-year research and innovation programme of the European Union. This autumn, they will decide on the Parliament’s proposal to increase its budget from €100bn to €120bn.